share_log

Piper Sandler Downgrades Achilles Therapeutics to Neutral, Lowers Price Target to $2

Piper Sandler Downgrades Achilles Therapeutics to Neutral, Lowers Price Target to $2

派珀·桑德勒将Achilles Therapeutics的评级下调至中性,将目标股价下调至2美元
Moomoo 24/7 ·  04/05 06:32

Piper Sandler analyst Joseph Catanzaro downgrades Achilles Therapeutics (NASDAQ:ACHL) from Overweight to Neutral and lowers the price target from $8 to $2.

派珀·桑德勒分析师约瑟夫·卡坦扎罗将Achilles Therapeutics(纳斯达克股票代码:ACHL)的评级从增持下调至中性,并将目标股价从8美元下调至2美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发